IMNM
Price
$16.54
Change
-$0.89 (-5.11%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.6B
126 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.98
Change
-$0.27 (-6.35%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
236.86M
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs VYGR

Header iconIMNM vs VYGR Comparison
Open Charts IMNM vs VYGRBanner chart's image
Immunome
Price$16.54
Change-$0.89 (-5.11%)
Volume$62.57K
Capitalization1.6B
Voyager Therapeutics
Price$3.98
Change-$0.27 (-6.35%)
Volume$6.66K
Capitalization236.86M
IMNM vs VYGR Comparison Chart in %
IMNM
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMNM vs. VYGR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (IMNM: $17.43 vs. VYGR: $4.25)
Brand notoriety: IMNM and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 96% vs. VYGR: 43%
Market capitalization -- IMNM: $1.6B vs. VYGR: $236.86M
IMNM [@Biotechnology] is valued at $1.6B. VYGR’s [@Biotechnology] market capitalization is $236.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 5 bearish.
  • VYGR’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а +13.55% price change this week, while VYGR (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($1.6B) has a higher market cap than VYGR($237M). IMNM YTD gains are higher at: 64.124 vs. VYGR (-25.044). VYGR has higher annual earnings (EBITDA): -119.18M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. VYGR (43.9M). IMNM has less debt than VYGR: IMNM (4.14M) vs VYGR (40.2M). VYGR has higher revenues than IMNM: VYGR (42.6M) vs IMNM (12.6M).
IMNMVYGRIMNM / VYGR
Capitalization1.6B237M676%
EBITDA-187.92M-119.18M158%
Gain YTD64.124-25.044-256%
P/E RatioN/A6.00-
Revenue12.6M42.6M30%
Total Cash268M43.9M610%
Total Debt4.14M40.2M10%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMSYX15.390.05
+0.33%
MFS Blended Research Mid Cap Eq R6
FRBAX29.460.07
+0.24%
JHancock Regional Bank A
GFVCX13.930.03
+0.22%
Goldman Sachs Focused Value C
HBLSX15.250.03
+0.20%
Hartford Balanced Income R4
IASSX10.640.01
+0.09%
VY® American Century Sm-Mid Cp Val S

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.51%
IDYA - IMNM
57%
Loosely correlated
-0.19%
IPSC - IMNM
54%
Loosely correlated
N/A
NRIX - IMNM
54%
Loosely correlated
-5.37%
RLAY - IMNM
53%
Loosely correlated
-1.91%
VYGR - IMNM
53%
Loosely correlated
-0.23%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.23%
RGNX - VYGR
54%
Loosely correlated
+0.43%
IMTX - VYGR
53%
Loosely correlated
+16.10%
KYMR - VYGR
52%
Loosely correlated
+0.25%
IMNM - VYGR
52%
Loosely correlated
-0.51%
XNCR - VYGR
51%
Loosely correlated
-3.23%
More